DexCom Valuation
| DC4 Stock | 77.31 3.70 4.57% |
At this time, the firm appears to be undervalued. DexCom Inc shows a prevailing Real Value of USD88.4 per share. The current price of the firm is USD77.31. Our model computes the value of DexCom Inc from reviewing the firm fundamentals such as Net Income of 154.7 M, price to sales of 17.58 X, and EBITDA of 377.9 M as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that DexCom's price fluctuation is very steady at this time. Calculation of the real value of DexCom Inc is based on 3 months time horizon. Increasing DexCom's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
DexCom's intrinsic value may or may not be the same as its current market price of 77.31, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 77.31 | Real 88.4 | Hype 77.31 | Naive 79.79 |
The intrinsic value of DexCom's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DexCom's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DexCom Inc helps investors to forecast how DexCom stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DexCom more accurately as focusing exclusively on DexCom's fundamentals will not take into account other important factors: DexCom Total Value Analysis
DexCom Inc is currently anticipated to have takeover price of 42.38 B with market capitalization of 48.62 B, debt of 1.7 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DexCom fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.38 B | 48.62 B | 1.7 B |
DexCom Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of DexCom implies not a very effective usage of assets in January.DexCom Profitability Analysis
The company reported the revenue of 2.45 B. Net Income was 154.7 M with profit before overhead, payroll, taxes, and interest of 0.About DexCom Valuation
The stock valuation mechanism determines DexCom's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of DexCom Inc based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of DexCom. We calculate exposure to DexCom's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DexCom's related companies.8 Steps to conduct DexCom's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates DexCom's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct DexCom's valuation analysis, follow these 8 steps:- Gather financial information: Obtain DexCom's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine DexCom's revenue streams: Identify DexCom's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research DexCom's industry and market trends, including the size of the market, growth rate, and competition.
- Establish DexCom's growth potential: Evaluate DexCom's management, business model, and growth potential.
- Determine DexCom's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate DexCom's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for DexCom Stock Analysis
When running DexCom's price analysis, check to measure DexCom's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DexCom is operating at the current time. Most of DexCom's value examination focuses on studying past and present price action to predict the probability of DexCom's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DexCom's price. Additionally, you may evaluate how the addition of DexCom to your portfolios can decrease your overall portfolio volatility.